TGFβRI-IN-4

TGFβRI-IN-4 is a highly potent and orally active TGFβ receptor type I (TGFβRI) inhibitor, with IC50s of 44 nM and 42.5 nM for ALK5 and NIH3T3. TGFβRI-IN-4 can suppress tumor growth and tumor weight in tumor xenograft model[1].

Product Specifications

CAS Number

[2421135-03-5]

UNSPSC

12352005

Target

TGF-β Receptor

Type

Reference compound

Related Pathways

TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/tgfβri-in-4.html

Solubility

10 mM in DMSO

Smiles

CC(O)(C1=CC(NC2=CC(OC3=CN(N=C3C4CC(F)(C4)F)C5CC5)=CC=N2)=CC=N1)C

Molecular Formula

C23H25F2N5O2

Molecular Weight

441.47

References & Citations

[1]Xu G, et al. Synthesis and biological evaluation of 4- (pyridin-4-oxy) -3- (3,3-difluorocyclobutyl) -pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors. Eur J Med Chem. 2020;198:112354.